Caxton Associates (New York)’s Agenus AGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGEN
DTC
SI
AG
Caxton Associates (New York)'s AGEN Position: Q4 2023 in Review
Caxton Associates (New York) sold out of Agenus (AGEN) in Q4 2023, closing a stake of 19,512 shares — an estimated $441K sold.
Caxton Associates (New York) first reported a position in AGEN in Q4 2019 and held it in 4 quarters. The position peaked at $441K in Q3 2023. 169 funds tracked by Wall St. Rank hold AGEN as of Q4 2023.
- Caxton Associates (New York) reported no remaining Agenus position as of Q4 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 19,512 Agenus shares in Q4 2023, an estimated $441K.
- Caxton Associates (New York) first reported a position in Agenus in Q4 2019 and held it in 4 quarters.
- Caxton Associates (New York)'s Agenus position peaked at $441K in Q3 2023.
- 169 funds tracked by Wall St. Rank held Agenus as of Q4 2023.
Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.